Your search matched 222 results
A busy week in Washington | Blog
So, a lot happened in Washington this week… which we won’t be commenting on!
Read this and more in this week's TWTW!
Take a look at the latest insights in this week’s issue of The Week That Was.
No matter whether you were the lone staffer in your office or relaxing on a beach somewhere this past week, we’ve got the run down on the latest healthcare headlines—the good, the bad and the ugly—to help you get you back up to speed.
The Week That Was: ... | Blog
It’s all in the latest edition of The Week that Was.
It was another intense week in healthcare headlines.
Everyone seems to be talking about digital health, but what does that really look like in action?
Climate change is named a top 10 health threat and we’ve broken down the conundrum for pharma companies regarding activating on the issue.
In case you haven’t heard, it’s the New Year.
Drug makers aren’t the only ones under pressure for high costs.
Our team kept an eye on a number of stories about opioid “pledges,” top-line data communications and, as always, drug pricing.
(Yeah, Weird Week) | Blog
Good morning, readers!
President Trump and HHS Secretary Azar gave a slightly delayed, much anticipated speech on the Administration’s Blueprint to lower drug prices.
The prevalence of these life threatening conditions is increasing and medical scientists can’t seem to figure out why.
From new hires to emerging partnerships, Apple's recent actions reveal increased focus on revolutionizing healthcare
Last week, Big Blue extended its maternity leave from 14 weeks of paid time off to up to 20 weeks.
Last week was the equivalent of editorial catnip for our team.
Medicine’s #MeToo Moment | Blog
What a week!
We’ve got a busy week behind us and another underway so let’s get to it.
Hazy, Not So Lazy, Days | Blog
Dive into the dog days with us in this edition of The Week That Was…
Let’s take stock of last week’s sweets, scary stuff, as well as the inevitable sour apple just in case you missed them.
Spent last week watching Shaun White win his third gold medal?
Bring on the Sunshine | Blog
Last week, we witnessed biotech billionaires get charged with fraud for misleading investors and watched Memorial
Before we fade into a tryptophan-induced slumber, let’s review some of the big announcements from last week.
FDA Lost That Lovin’ Feeling | Blog
The FDA lost its lovin’ feeling this week and we kept busy evaluating Louisiana’s new drug pricing proposal and watching not one, but two, Congressional hearings covering both Right to Try and the national opioid epidemic.
It’s Monday, we’re caffeinated and its one week away from Mother’s Day (you’re welcome).
The Heat Is On... | Blog
Last week’s headlines were nearly as extreme.
Betting, Biohacking & BYOD | Blog
CEO’s were making headlines last week for a host of reasons.
New Ads for New Era | Blog
This week, two of the world’s biggest digital players started unveiling new ad units and approaches designed for how we use digital tools right now.
We’ve Got Stamina | Blog
FDA had another busy week: recalling Ritz crackers & goldfish, committing to create a modernized definition of what is a “dairy product,” approving new magnetic systems to prevent breast cancer patients from being exposed to excessive radioactive materials during biopsies.